Latest Articles

Public health recommendations for Lp(a) measurement

Single-Pill Combinations in Dyslipidemia

This review describes the potential benefits of combination treatment and presents data supporting the use of single-pill combination (SPC) for increasing exposure to lipid-lowering treatment (LLT).

The European experience: Swedeheart and AIFA registries

Highlights on the most recent real-world data on the use of PCSK9 inhibitors, including those from the Swedeheart and AIFA registries.

Statin/Ezetimibe Combination VS Statin Monotherapy

Use of Lipid-Lowering Therapies Over 2 Years

Unmet clinical needs in the management of VTE in at-risk patients

VTE incidence after cesarean delivery

Venous thromboembolism incidence in patients recommended for pharmacologic prophylaxis after cesarean delivery based on different risk stratification guidelines.

APSC Consensus Recommendations on Dyslipidemia

ESC Lp(a) in Clinical practice EAS Consensus statement